financetom
Business
financetom
/
Business
/
MKS Instruments Q2 Non-GAAP Earnings, Revenue Increase; Q3 Guidance Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MKS Instruments Q2 Non-GAAP Earnings, Revenue Increase; Q3 Guidance Issued
Aug 6, 2025 3:12 PM

05:54 PM EDT, 08/06/2025 (MT Newswires) -- MKS Instruments (MKSI) reported Q2 non-GAAP earnings late Wednesday of $1.77 per diluted share, up from $1.53 a year earlier.

Analysts polled by FactSet expected $1.64.

Revenue for the quarter ended June 30 was $973 million, up from $887 million a year earlier.

Analysts surveyed by FactSet expected $932.4 million.

For Q3, the company expects non-GAAP EPS of $1.80, plus or minus $0.29, on revenue of $960 million, plus or minus $40 million. Analysts polled by FactSet expect EPS of $1.70 on revenue of $946.1 million.

Shares of the company were up 3.2% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stack Capital Group Invests US$10 Million in CoreWeave
Stack Capital Group Invests US$10 Million in CoreWeave
Mar 5, 2025
08:10 AM EST, 03/05/2025 (MT Newswires) -- Stack Capital Group ( STCGF ) on Wednesday said it has invested US$10 million into CoreWeave, a cloud-based AI-infrastructure company that provides data centers delivering high-performance capabilities. Given its growing data center presence across the United States, Europe, and Canada, CoreWeave is extremely well-positioned to continue capitalizing on accelerating global demand for AI...
CareRx Q4 Net Loss Narrows, Adjusted Profit Beats Estimate
CareRx Q4 Net Loss Narrows, Adjusted Profit Beats Estimate
Mar 5, 2025
08:08 AM EST, 03/05/2025 (MT Newswires) -- CareRx ( CHHHF ) , which provides pharmacy services to seniors in care communities, on Wednesday said its fourth-quarter net loss narrowed and adjusted earnings per share beat estimates. The net loss came in at $2.2 million or $0.04 per share, compared with a net loss of $3.7 million or $0.06 per share,...
Novo Nordisk to offer lower-priced versions of Wegovy for cash-paying customers
Novo Nordisk to offer lower-priced versions of Wegovy for cash-paying customers
Mar 5, 2025
March 5 (Reuters) - Novo Nordisk said on Wednesday it would offer lower-priced doses of its weight loss drug Wegovy at a reduced cost of $499 per month for cash-paying customers. The offer will be available for uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity medicines, the company said. ...
Axon Enterprise Plans $1.5 Billion Senior Notes Offering
Axon Enterprise Plans $1.5 Billion Senior Notes Offering
Mar 5, 2025
08:10 AM EST, 03/05/2025 (MT Newswires) -- Axon Enterprise ( AXON ) said Wednesday it plans to sell a total of $1.5 billion of senior notes due 2030 and 2033 in a private offering. The company said it intends to use the net proceeds for general corporate purposes. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved